Cargando…
Discharge Outcomes of Severely Sick Patients Hospitalized with Multidrug-Resistant Tuberculosis, Comorbidities, and Serious Adverse Events in Kyrgyz Republic, 2020–2022
Patients with multidrug-resistant tuberculosis (MDR-TB) who have comorbidities, complications, and experience serious adverse events (SAEs) are at substantial risk of having unfavorable hospital outcomes. We assessed characteristics and discharge outcomes of 138 MDR-TB patients hospitalized in the N...
Autores principales: | Alumkulova, Gulzat, Hazoyan, Anna, Zhdanova, Elena, Kuznetsova, Yuliia, Tripathy, Jaya Prasad, Sargsyan, Aelita, Goncharova, Olga, Kadyrov, Meder, Istamov, Kylychbek, Ortuño-Gutiérrez, Nimer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384159/ https://www.ncbi.nlm.nih.gov/pubmed/37505634 http://dx.doi.org/10.3390/tropicalmed8070338 |
Ejemplares similares
-
The Trend, Characteristics and Treatment Outcomes in Patients with Tuberculosis Undergoing Thoracic Surgery in the Kyrgyz Republic between 2017 and 2021
por: Sakmamatov, Konushbek, et al.
Publicado: (2023) -
Quality of Electronic TB Register Data Compared with Paper-Based Records in the Kyrgyz Republic
por: Shauer, Daniil, et al.
Publicado: (2023) -
Delays in Treatment Initiation and Treatment Outcomes in Patients with Tuberculosis in the Kyrgyz Republic: Are There Differences between Migrants and Non-Migrants?
por: Istamov, Kylychbek, et al.
Publicado: (2023) -
Contact Tracing and Tuberculosis Preventive Therapy for Household Child Contacts of Pulmonary Tuberculosis Patients in the Kyrgyz Republic: How Well Are We Doing?
por: Kadyrov, Meder, et al.
Publicado: (2023) -
Time to Treatment and Risk Factors for Unsuccessful Treatment Outcomes among People Who Started Second-Line Treatment for Rifampicin-Resistant or Multi-Drug-Resistant Tuberculosis in the Kyrgyz Republic, 2021
por: Kyrbashov, Bolot, et al.
Publicado: (2023)